{"url_path":"/sec/cldi/8-k/2026-07-16/item-2-03","section_key":"item-2-03","section_title":"Item 2.03 Creation of a Direct Financial Obligation or an Obligation Under an Off-Balance Sheet Arrangement of a Registrant.**","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-07-16","source_url":"https://www.sec.gov/Archives/edgar/data/1855485/0001493152-26-033594-index.html","accession_number":"0001493152-26-033594","cik":"0001855485","ticker":"CLDI","issuer_name":"Calidi Biotherapeutics, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1855485/0001493152-26-033594-index.html","primary_entity_key":"0001855485","primary_entity_name":"Calidi Biotherapeutics, Inc."},"word_count":50,"has_tables":true,"body_markdown":"** **\n\n**Item\n2.03. Creation of a Direct Financial Obligation or an Obligation Under an Off-Balance Sheet Arrangement of a Registrant.**\n\n \n\nThe\ninformation set forth under Item 1.01 of this Current Report on Form 8-K under the caption “Entry into a Material Definitive Agreement,\nis incorporated by reference into this Item 2.03."}